首页> 外文学位 >Discovery of first indications of multidrug resistance in a teleost embryo, using the model organism zebrafish (Danio rerio).
【24h】

Discovery of first indications of multidrug resistance in a teleost embryo, using the model organism zebrafish (Danio rerio).

机译:使用模型生物斑马鱼(Danio rerio)在硬骨鱼胚胎中发现了多重耐药性的第一个迹象。

获取原文
获取原文并翻译 | 示例

摘要

The classic calcein-AM accumulation assay of multidrug resistance studies has been used in several vertebrate systems but not yet in zebrafish ( Danio rerio) or their embryos. Here we describe the adaptation of this assay for use in zebrafish and include details on the approach used to develop an epifluorescence microscopy protocol for viewing and measuring fluorescence of treated embryos---the development of which facilitated further investigations into the early zebrafish embryo's capacity for multidrug resistance as a defense mechanism.;Multidrug resistance (MDR) transporters of the multidrug resistance-associated protein (Mrp) and P-glycoprotein (P-gp) families were examined during early development in zebrafish. We investigated transport activity in the presence and absence of MDR inhibitors MK571 (MRP) and PSC833 (P-gp): Mrp-mediated transport activity was most apparent in the pre-midblastula transition (pre-MBT) embryo, although limited activity was also evident post-midblastula transition (post-MBT), and P-gp-mediated transport was not detectable at either developmental stage. These findings indicate that MDR is active in the early embryo and provides defensive capabilities against accumulation of select toxicants.;While investigating the existence and behavior of transcript expression of select MDR-affiliated genes in the early developing zebrafish ( Danio rerio) embryo, results of normalizing transcript expression according to an established conservative method seemed to suggest that transcript expression was occurring during early development, although patterns in expression were not observable and an exact behavior was unknown. We therefore alternately explored a course of data treatment involving a non-conservative approach to normalization calculations that accounted only for inter-experimental variation. Though both experimental approaches were valid, they did not show the same interpretation of data. Therefore a power analysis-based investigation of suitable calculation methods for comparatively analyzing quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) data was used to assess the most appropriate analysis method for the experimental design: transcript expression of the MDR-affiliated genes abcb1, abcc1, abcc2, and abcg2a in early developing zebrafish. We concluded that transcript expression of select MDR genes is measurable in the early zebrafish embryo and that experimental design should take into consideration that the selection of a course of data treatment, in the form of normalization calculations, affects calculated expression values.
机译:经典的钙黄绿素-AM累积多药耐药性研究已用于多个脊椎动物系统,但尚未用于斑马鱼(Danio rerio)或其胚胎中。在这里,我们描述了该检测方法在斑马鱼中的适应性,并详细介绍了用于开发落射荧光显微镜协议以查看和测量处理过的胚胎的荧光的方法的方法-该方法的发展有助于进一步研究斑马鱼早期胚胎的能力。作为防御机制。在斑马鱼的早期发育过程中,研究了多药耐药相关蛋白(Mrp)和P-糖蛋白(P-gp)家族的多药耐药(MDR)转运蛋白。我们调查了在存在和不存在MDR抑制剂MK571(MRP)和PSC833(P-gp)的情况下的转运活性:Mrp介导的转运活性在中胚层转化前(MBT)胚胎中最为明显,尽管活性也很有限。在两个发育阶段均未检测到明显的中胚层过渡期(MBT后)和P-gp介导的转运。这些发现表明MDR在早期胚胎中具有活性,并提供防御某些有毒物质积累的防御能力。;在调查斑马鱼早期发育(Danio rerio)胚胎中某些MDR相关基因的转录表达的存在和行为时,根据确定的保守方法对转录本表达进行归一化似乎表明转录本表达是在早期发育中发生的,尽管观察不到表达模式并且确切的行为尚不清楚。因此,我们另辟explore径地探索了一种数据处理过程,该过程涉及非保守方法进行归一化计算,该方法仅考虑了实验间的差异。尽管这两种实验方法都是有效的,但它们对数据的解释不同。因此,基于功率分析的适当计算方法的调查,用于比较分析实时定量逆转录聚合酶链反应(qRT-PCR)数据,以评估最适合实验设计的分析方法:MDR关联的转录表达斑马鱼早期发育中的基因abcb1,abcc1,abcc2和abcg2a。我们得出的结论是,在斑马鱼早期的胚胎中可测量出所选MDR基因的转录表达,并且实验设计应考虑到以标准化计算形式进行的数据处理过程的选择会影响计算的表达值。

著录项

  • 作者单位

    University of California, Santa Cruz.;

  • 授予单位 University of California, Santa Cruz.;
  • 学科 Biology Cell.;Health Sciences Toxicology.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 142 p.
  • 总页数 142
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号